secwatch.observer — SEC 8-K summary
======================================

Issuer:     UNITED GUARDIAN INC (UG)
CIK:        0000101295
Form:       8-K
Filed at:   2026-08-07T14:30:21+00:00
Accession:  0001171843-26-005349
Event type: earnings
Sentiment:  positive
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

United-Guardian Q2 net income up 16% to $728,579; sales up 10% to $3.1M
-----------------------------------------------------------------------

- Q2 net sales $3,108,267, up 10% from $2,838,225; net income $728,579 ($0.16/diluted), up 16% from $626,826 ($0.14).
- Six-month net sales $5,980,489, up 12% from $5,319,352; net income $1,547,481 ($0.34), up 30% from $1,187,721 ($0.26).
- Cosmetic ingredient sales up 44% in Q2 and 34% in H1, driven by resumed purchasing from largest distributor Ashland Specialty Ingredients (ASI).
- Pharmaceutical sales up 1% in Q2 and 11% in H1, led by Renacidin; company focused on growth plan for rest of 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/101295/000117184326005349/0001171843-26-005349-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/101295/000117184326005349/f8k_080726.htm
  HTML page:      https://secwatch.observer/filing/0001171843-26-005349

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer